Accumulated data showed that VDAC1 overexpression is common in many diseases (T2DM, cancer, Alzheimer’s’ disease, Parkinson’s disease, cardiovascular diseases, and more) that are affected by metformin-affecting diseases (Table 1). Here, VDAC1 is linked to type 2 diabetes mellitus.